longbridge

MiNK Therapeutics

INKT
----

All Shareholders

Shareholder Type

  • Public companies42.67%
  • Public and others36.42%
  • Individuals & Insiders16.92%
  • Institutions4.00%

Major Shareholders

Major Shareholders Latest
Shareholder
Agenus Inc.
42.67%2.18M1.15%+0
Yekaterina ChudnovskyBoard Observer
9.09%464.00K0.25%+0
Garo ArmenExecutive Chairman
3.39%172.80K0.09%+0
Vanguard Capital Management, LLC
1.51%76.95K0.15%+9.30K
Jennifer BuellCo-Founder, President, CEO & Director
1.45%74.20K0.32%+16.25K
DNB Asset Management AS
1.08%55.14K--+55.14K
Brian CorveseIndependent Director
1.04%53.14K0.03%+1.44K
Ulf WiinbergIndependent Director
0.99%50.48K0.02%+1.13K
Peter BehnerIndependent Director
0.45%22.92K0.03%+1.31K
Barbara RyanIndependent Director
0.43%21.97K<0.01%+0
Longbow Finance SA
0.33%16.67K<0.01%+0
Geode Capital Management, LLC
0.31%15.57K0.04%-1.77K
Citadel Advisors LLC
0.30%15.44K--+15.44K
BlackRock, Inc.
0.26%13.38K0.14%+7.18K
UBS Asset Management AG
0.10%4.89K0.21%-10.32K
John HolcombIndependent Director
0.07%3.46K0.02%+1.09K
Steward Partners Investment Advisory, LLC
0.04%2.00K<0.01%+0
U.S. Bancorp Asset Management, Inc.
0.04%2.00K--+2.00K
Fédération des caisses Desjardins du Québec
<0.01%500.00--+500.00
Paladin Partners, LLC
<0.01%500.00<0.01%-500.00
© 2026 Longbridge｜Terms of ServicePrivacy Policy